Cytokinetics (CYTK) Misses Q4 EPS by 24c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $84.87 --0%
EPS Growth %: -45.5%
Financial Fact:
Operating loss: 32.49M
Today's EPS Names:
CCEL, MHGU, PLG, More
EPS Growth %: -45.5%
Financial Fact:
Operating loss: 32.49M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($1.45), $0.24 worse than the analyst estimate of ($1.21). Revenue for the quarter came in at $1.96 million versus the consensus estimate of $7.45 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Citi initiates Bel Fuse coverage with Buy rating, $325 target
- JPMorgan Upgrades Largan Precision Co Ltd. (3008:TT) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
